 This review provides a detailed analysis of synthetic routes towards commercial drug compounds with five-membered heterocycles, focusing on the assembly of their heterocyclic core and using examples from the top 200 best-selling drugs of recent years. This article was authored by Marcus Bauman, Ian R. Baxendale, Steven Viedle, and others.